Maldisa, Madzda .

HRN: 20-92-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2024
AMPICILLIN 1GM (VIAL)
05/08/2024
05/14/2024
IVT
2g
Q6hrs
Prom
Waiting Final Action 
05/10/2024
CO-AMOXICLAV 625MG (TAB)
05/10/2024
05/17/2024
PO
625 Mg Gab
BID
Sp Nsvd With 2 Rmle And Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: